News

J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 11 May 2026, inter alia, have recommended the final dividend of Rs 9.3 per equity Share (i.e. 930%) , subject to the approval of the shareholders.

Net profit of J B Chemicals & Pharmaceuticals declined 30.42% to Rs 101.37 crore in the quarter ended March 2026 as against Rs 145.69 crore during the previous quarter ended March 2025. Sales declined 4.77% to Rs 904.23 crore in the quarter ended March 2026 as against Rs 949.48 crore during the previous quarter ended March 2025.For the full year,net profit rose 7.56% to Rs 709.47 crore in the year ended March 2026 as against Rs 659.58 crore during the previous year ended March 2025. Sales rose 5.87% to Rs 4147.79 crore in the year ended March 2026 as against Rs 3917.99 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales904.23949.48 -5 4147.793917.99 6 OPM %22.2423.85 -26.7026.34 - PBDT211.88239.47 -12 1162.011058.43 10 PBT161.87193.03 -16 979.51887.39 10 NP101.37145.69 -30 709.47659.58 8 Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 May 2026.

J B Chemicals & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 April 2026.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 31,160 equity shares under ESOS on 19 February 2026. Consequently, the issued, subscribed and paid-up capital has increased from 16,05,27,546 equity shares of Re. 1 each to 16,05,58,706 equity shares of Re. 1 each. Powered by Capital Market - Live News